BioAgilytix Is Re-approved and Registered For The French Research Tax Credit (CIR)

The Latest News from BioAgilytix

BioAgilytix Becomes the First CRO to Validate Meso Scale Discovery’s V-PLEX Human Cytokine 30-Plex Assay
5 March, 2014

BioAgilytix Becomes the First CRO to Validate Meso Scale Discovery’s V-PLEX Human Cytokine 30-Plex Assay

Learn about the MSD platform here.BioAgilytix, a leading bioanalytical testing laboratory specializing in immunoassays and cell-based assays, has validated Meso Scale Discovery’s V-PLEX™ Human Cytokine 30-plex assay, making it the…

Read More

BioAgilytix Offers New Capabilities in Support of Biosimilar Development
25 February, 2014

BioAgilytix Offers New Capabilities in Support of Biosimilar Development

BioAgilytix, a leading bioanalytical testing laboratory specializing in immunoassays and cell-based assays, announced today our support of development and release testing for biosimilar large molecule therapeutics.  “Our expanded capability and…

Read More

BioAgilytix Welcomes Kelley Intehar as Senior Director of Product Management
13 January, 2014

BioAgilytix Welcomes Kelley Intehar as Senior Director of Product Management

BioAgilytix, a leading provider of contract bioanalytical testing services, today announced that Kelley Intehar has joined the company as Senior Director of Product Management. Kelley is a seasoned science and…

Read More

BioAgilytix Names Jim Datin Chief Executive Officer
10 December, 2013

BioAgilytix Names Jim Datin Chief Executive Officer

BioAgilytix, a leading provider of contract bioanalytical testing services, today announced that Jim Datin has joined the company as Chief Executive Officer. Jim is a seasoned executive with significant experience…

Read More

bioagilytix adds 2 gyro workstations immunoassay
5 November, 2013

BioAgilytix adds 2 Gyros Workstations to Existing Suite of Immunoassay Platforms

BioAgilytix, a leading bioanalytical testing laboratory specializing in immunoassays and cell-based assays, announced today the introduction of two Gyrolab xP workstations to its existing suite of immunoassay platforms. Dr. Afshin Safavi,…

Read More